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Background: The prevalence of craniofacial pain disorders show sexual dimorphism with 
generally more common appearance in women suggesting the influence of estradiol, but the 
exact cause remains unknown. The common point in the pathogenesis of these disorders is the 
activation of trigeminal system. One of the animal experimental models of trigeminal activa-
tion is the orofacial formalin test, in which we investigated the effect of chronic 17β-estradiol 
pretreatment on the trigeminal pain-related behavior and activation of trigeminal second-order 
neurons at the level of spinal trigeminal nucleus pars caudalis (TNC).
Methods: Female Sprague Dawley rats were ovariectomized and silicone capsules were 
implanted subcutaneously containing cholesterol in the OVX group and 17β-estradiol and 
cholesterol in 1:1 ratio in the OVX+E
2
 group. We determined 17β-estradiol levels in serum 
after the implantation of capsules. Three weeks after operation, 50 µL of physiological saline 
or 1.5% of formalin solution was injected subcutaneously into the right whisker pad of rats. 
The time spent on rubbing directed to the injected area and c-Fos immunoreactivity in TNC 
was measured as the formalin-induced pain-related behavior, and as the marker of pain-related 
neuronal activation, respectively.
Results: The chronic 17β-estradiol pretreatment mimics the plasma levels of estrogen occurring 
in the proestrus phase and significantly increased the formalin-induced pain-related behavior 
and neuronal activation in TNC.
Conclusion: Our results demonstrate that the chronic 17β-estradiol treatment has strong 
 pronociceptive effect on orofacial formalin-induced inflammatory pain suggesting modulatory 
action of estradiol on head pain through estrogen receptors, which are present in the trigeminal 
system.
Keywords: c-Fos, headache, pain, sexual dimorphism, trigeminal system
Introduction
The perception of intensity of pain or the responses to painkillers show differences 
between the sexes.1,2 Lower tolerance for pain, greater ability to discriminate painful 
sensations, lower pain thresholds and higher pain ratings can be observed in women.1–3 
Moreover, the localization of pain according to body parts can amplify this sex-related 
difference, because this discrepancy is more pronounced in the case of craniofacial pain, 
which is usually more common in women. For example, temporomandibular disorders, 
mainly manifested in paroxysmal pain in the masticatory muscles and temporoman-
dibular joints,4 are three times more prevalent in women.5 Also, more women than men 
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suffer from trigeminal neuralgia,6,7 which is characterized by 
recurrent unilateral brief electric shock-like pains, abrupt 
in onset and termination, limited to the distribution of one 
or more divisions of the trigeminal nerve and triggered by 
innocuous stimuli.8 Significant sex-related differences can 
be observed among the primary headache disorders as well. 
Women also have higher prevalence of tension-type headache 
than men,9 and migraine is three times more common in 
females compared to males.10 In contrast, cluster headache 
is five times more frequent in men than women.11
These data indicate that sex hormones may influence the 
development of trigeminal pain conditions, which is underlined 
by the observations, that migraine without aura usually starts 
after menarche, tends to be related to menstrual cycle and ame-
liorates during pregnancy and after menopause in women.12 In 
addition, the appearance of migraine without aura is thought to 
be related to the fall in estrogen concentrations prior to men-
struation,12,13 while in migraine with aura an increase in attack 
frequency can be observed related to high estrogen levels, eg, 
pregnancy.14 Similarly, the marked female predominance appears 
only after puberty in the case of tension-type headache as well.15
Animal research data also show the presence of the sexual 
dimorphism and the modulatory effect of sex hormones on 
the orofacial pain;16 moreover, site-specific effect of sex hor-
mones on nociception was detected in rats as well.17 These 
experimental data might give useful information concerning 
the molecular mechanisms underlying the sex differences in 
pain conditions, but they are rather controversial.
Concerning the possible mechanisms, these sex-related 
differences in craniofacial pain disorders suggest that tri-
geminal neurons are sensitive to sex hormones, which can 
modulate their function. Hormonal receptors are present in 
both the trigeminal ganglion and the spinal trigeminal nucleus 
pars caudalis (TNC) providing the molecular basis for direct 
modulatory action on the peripheral and central sensitization 
in the trigeminal system.18–21 At present, however, the exact 
mechanisms underlying sex-related differences in the preva-
lence of these craniofacial pain conditions remain obscure.
To get further data on the role of estradiol in the sex-related 
trigeminal nociception, we investigated trigeminal pain-related 
behavior and c-Fos immunoreactivity – a morphological 
marker of trigeminal activation – in rats with stable low and 
stable high estrogen levels in the orofacial formalin test.
Materials and methods
animals
Fifty-five female Sprague Dawley rats weighing 150–250 g 
were used. The animals were raised and housed under 
 standard laboratory conditions (in an air-conditioned, 
humidity-controlled and ventilated room), with drinking 
water and regular rat chow available ad libitum on a 12 h- 
12 h dark–light cycle. The procedures used in this study 
followed the guidelines of the International Association 
for the Study of Pain and the directive of the European 
Economic Community (86/609/ECC). They were approved 
by the Committee of Animal Research at the University of 
Szeged (I-74-12/2012) and the Scientific Ethics Committee 
for Animal Research of the Protection of Animals Advisory 
Board (XXIV/352/2012). All efforts were made to minimize 
the number of animals used and their suffering.
Ovariectomy
The animals were ovariectomized under deep chloral hydrate 
(0.4 g/kg body weight, catalog ID: 23100; Sigma-Aldrich, 
St. Louis, MO, USA) anesthesia administered intraperitone-
ally. Prior to surgery, rats’ back were shaved with electric 
clippers and furs were removed completely. Cutasept was 
applied to the shaved area to disinfect the skin. Ovariectomy 
was preceded by a midline dorsal skin incision, 3 cm long, 
approximately half way between the middle of the back and 
the base of the tail. 1.5 cm long peritoneal incisions were 
made bilaterally. After access into the peritoneal cavity, the 
ovary and associated fat were easily found, and exteriorized 
by gentle retraction. Ligature of the blood vessels was also 
performed. The connection between the Fallopian tube and 
the uterine horn was cut and the ovaries were removed. 
Afterward, the animals were randomly divided into two 
groups: 1) In the OVX group, the rats had two 15 mm long 
silastic capsule (3.18 mm outer diameter and 1.57 mm inner 
diameter, catalog ID: 508–008; Dow Corning, Midland, 
Michigan, USA) filled with cholesterol (15 mg, catalog ID: 
C8667; Sigma-Aldrich) as control. 2) In the OVX+E
2
 group, 
the animals received two 15 mm long silastic capsule filled 
with an 1:1 mixture of 17β-estradiol (7.5 mg, catalog ID: 
75262; Fluka, Sigma-Aldrich) and cholesterol (7.5 mg). 
Capsules were inserted subcutaneously in the interscapular 
region. After implantation of capsules, peritoneal cavity and 
skin were closed with absorbable sutures. High degree of 
aseptic procedure was maintained throughout the operation. 
Surgical instruments were sterilized in 70% ethanol. During 
and after the surgery, animals were placed on heating plate 
and covered with paper in order to avoid hypothermia. The 
analgesia and attenuation of inflammation were provided 
by subcutaneous (sc) administration of carprofen (5 mg/
kg body weight) three times: once before the operation and 
twice after the surgery (24 and 48 hours).
 
Jo
ur
na
l o
f P
ai
n 
Re
se
ar
ch
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
16
0.
11
4.
10
4.
83
 o
n 
05
-N
ov
-2
01
8
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Journal of Pain Research  2018:11 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2013
The pronociceptive effect of 17β-estradiol pretreatment
Measurement of estradiol concentration
17β-estradiol concentration of serum was measured in both 
groups (n=5). The blood samples were taken weekly from 
the tail vein for 5 weeks. The serum was cleared from cel-
lular components of the blood by centrifugation at 12,000 
rpm for 10 minutes at 4°C and stored at –80°C until use. 
The concentrations were measured by using Estradiol EIA 
Kit (catalog ID: 582251; Cayman Chemical Company, Ann 
Arbor, MI USA) based on the guidelines of the manufacturer.
Behavioral test
Both groups (OVX and OVX+E
2
) of animals were divided 
further into two subgroups (n=10–12 per subgroup): In 
the OVX-Phys and OVX+E
2
-Phys subgroups, the animals 
received a sc injection of 50 µL physiological saline admin-
istered via a 26-gauge needle into the right whisker pad 
after 3 weeks of recovery following the ovariectomy. In the 
OVX-Form and OVX+E
2
-Form subgroups, the rats were 
injected with sc 50 µL 1.5% formalin solution (containing 
0.55% formaldehyde) diluted in physiological saline via a 
26-gauge needle into the right whisker pad. According to 
Clavelou et al, this concentration is the most appropriate to 
detect changes in pain-related behavior of rats.22
The testing procedures were performed during the light 
phase (between 8 a.m. and 2 p.m.) in a quiet room. The 
test box was a 30×30×30 cm glass terrarium with mirrored 
walls. For the off-line analysis of rubbing activity directed to 
the whisker pad, the behavior of the individually tested rats 
was recorded with a video camera (Logitech HD Webcam 
C615; Logitech Inc., Newark, NJ, USA) situated 1 m above 
the terrarium. After 10 minutes habituation in the test box, 
the whisker pads of the rats were injected with formalin or 
physiological saline and the animals were replaced imme-
diately back in the chamber for 45 minutes. The rats did not 
receive any food or water during the observation period. The 
test box was cleaned and decontaminated after each animal. 
An observer blind to the experimental procedures analyzed 
the recorded videos. The 45-minute recording period was 
divided into 15×3 minutes blocks and the total time (number 
of seconds) spent on rubbing directed to the injected area 
with the ipsilateral fore- or hindpaw was measured in each 
block and defined as the nociceptive score for that block. The 
grooming activity of physiological saline-injected animals 
was used as control based on an earlier study.22
c-Fos immunohistochemistry
Four hours after the formalin or physiological saline injec-
tion, the rats were perfused transcardially with 100 mL of 
phosphate-buffered saline, followed by 500 mL of 4% para-
formaldehyde in phosphate buffer under deep chloral hydrate 
anesthesia. The medullary segment containing the TNC 
between +1 and –5 mm from the obex was removed, postfixed 
overnight for immunohistochemistry in the same fixative 
and cryoprotected (10% sucrose for 2 hours, 20% sucrose 
until the blocks sank and 30% sucrose overnight). Before 
sectioning, each segment was marked with a small incision 
on the ventral and left (contralateral) side of the tissue block, 
allowing side discrimination during the quantification pro-
cess; 30 µm transverse cryostat sections were cut through the 
rostrocaudal axis from the beginning of the TNC and were 
serially collected in wells containing cold PBS. Each well 
contained every tenth section at 0.3 mm intervals along the 
rostrocaudal axis (15 levels [sections]/well). The free-floating 
sections were rinsed in PBS and immersed in 0.3% H
2
O
2
 
in PBS for 30 minutes to suppress endogenous peroxidase 
activity. After several rinses in PBS containing 1% Triton 
X-100 (PBST), sections were incubated at room temperature 
overnight in PBST containing rabbit anti-rat c-Fos polyclonal 
antibody (catalog ID: sc-52, RRID: AB_2106783; Santa Cruz 
Biotechnology Inc., Dallas, TX, USA) at a dilution of 1:2000. 
The immunohistochemical reaction was visualized by using 
Vectastain Elite Avidin-Biotin Kits (catalog ID: PK6101; Vec-
tor Laboratories, Burlingame, CA, USA). Briefly, the sections 
were incubated at room temperature for 2 hours in PBST 
containing goat anti-rabbit biotinylated secondary antibody. 
After several rinses in PBST, and incubation at room tempera-
ture for 2 hours in PBST containing avidin and biotinylated 
horseradish peroxidase, the immunohistochemical labeling 
was visualized with 3,3′-diaminobenzidine intensified with 
nickel ammonium sulphate. The specificity of the immune 
reactions was checked by omitting the primary antiserum.
The counting of immunoreactive (IR) cells in the TNC 
was performed by an observer blinded to the experimental 
procedures under the 10× objective of a Nikon Optiphot-2 
light microscope in every tenth transverse section in each 
animal. Before the counting, the location of each section 
along the rostrocaudal axis and the location of the TNC on 
each medullary section were determined by means of The Rat 
Brain in Stereotaxic Coordinates Atlas.23 The c-Fos neurons 
with obvious specific nuclear staining were counted in the 
TNC both ipsilaterally and contralaterally to the formalin or 
physiological saline injection.
statistical analysis
For statistical comparison of 17β-estradiol concentration 
of serum in the two groups (OVX and OVX+E
2
), we used 
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 two-way repeated-measures ANOVA. Pairwise comparisons 
of group means were based on the estimated marginal means 
with Sidak adjustment for multiple comparisons.
In the behavioral study, we compared the nociceptive 
responses in two time periods as described by Clavelou 
et al.22 The first 3 minutes (block 1) are characterized by 
intensive rubbing activity and defined as the first phase. 
Following a relatively relaxed period, the rubbing intensi-
fies again between about 12 and 45 minutes (second phase) 
and remains high for a longer period of time (blocks 5–15), 
which is defined as the second phase. For the comparison 
of the rubbing activities between subgroups (OVX-Phys, 
OVX-Form, OVX+E
2
-Phys and OVX+E
2
-Form) in the first 
and second phase, we used one-way ANOVA followed by the 
Tamhane post hoc test.
The number of c-Fos-IR neurons in the various subgroups 
(OVX-Phys, OVX-Form, OVX+E
2
-Phys and OVX+E
2
-Form) 
were compared at each level of 0.3 mm (15 levels) along 
the rostrocaudal axis by using two-way repeated-measures 
ANOVA. There was no significant difference in the number 
of c-Fos-IR neurons between the contra- and ipsilateral sides 
in rats injected with sc physiological saline and the contralat-
eral sides in animals injected with sc formalin (OVX-Form 
and OVX+E
2
-Form); therefore, the data obtained from the 
contralateral sides of the subgroups injected with sc formalin 
(OVX-Form and OVX+E
2
-Form) were used as controls in 
the statistical analysis. Pairwise comparisons of subgroup 
means were based on the estimated marginal means with 
Sidak adjustment for multiple comparisons.
All tests were two-sided, and probability levels P<0.05 
were considered to be statistically significant. Group values 
are reported as mean ± standard error of the mean (SEM).
Statistical analysis of measurements was carried out with 
IBM SPSS Statistics, version 20 software (IBM Corporation, 
Armonk, NY, USA).
Results
estradiol concentration
Following the ovariectomy, in both groups, an approximate 
steady state status in serum concentration of 17β-estradiol 
was maintained for 5 weeks with an average value of 25.93 
pg/mL in the OVX group and 64.55 pg/mL in the OVX+E
2
 
group (Figure 1). In OVX+E
2
 group, the ovariectomized 
female rats received two silastic capsules containing in all 
15 mg 17β-estradiol, which chronic pretreatment keeps the 
serum concentration of 17β-estradiol at significantly higher 
level compared with the OVX group (***P<0.001; Figure 1). 
Although we did not find significant difference between 
the serum levels measured weekly in OVX+E
2
 group, a 
tendency of lower level in the fifth week can be observed 
(Figure 1). This result suggests that serum concentration 
of 17β-estradiol began to decrease in the fifth week simi-
larly to data published in an earlier work.24 Since a stable 
serum concentration was found from second to fourth week 
(Figure 1), we examined the potential modulating effect of 
chronic 17β-estradiol pretreatment in the third week fol-
lowing the ovariectomy and implantation of capsules. At 
this time point, the average estradiol concentration in the 
serum was 25.01 pg/mL in OVX group and 61.29 pg/mL in 
OVX+E
2
 group (Figure 1).
nociceptive response
The behavioral pattern following orofacial injection 
of formalin observed in the rats is in accordance with 
Figure 1 The concentration of 17β-estradiol in serum (pg/ml) in the OVX and OVX + e2 groups.
Notes: The chronic 17β-estradiol treatment significantly increases the serum concentration compared with the OVX group (***P<0.001).
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 previous findings.22,25,26 After the formalin injection, the rats 
immediately withdrew their heads, often accompanied by 
vocalization. Following their return to the observation box, 
the rats started to rub their whisker pad continuously and 
intensely with the ipsilateral forepaw accompanied often 
by the contralateral forepaw, and occasionally scraped the 
perinasal area with the ipsilateral hindpaw after a quiet 
period of ~20 seconds. This period, referred to as the first 
phase, lasted ~3–4 minutes, and was followed by a quiescent 
period of 9–10 minutes, separating the first phase from the 
second phase (Figure 2). The second phase was character-
ized by less intense, but continuous rubbing of the face, 
predominantly with the ipsilateral forepaw consorted often 
by the contralateral forepaw as well. This tonic phase lasted 
~30–33 minutes (Figure 2). In both subgroups injected with 
formalin (OVX-Form and OVX+E
2
-Form), the biphasic 
pain-related behavioral pattern can be observed (Figure 2). 
In the OVX+E
2
-Form subgroup, this pattern was clearly more 
pronounced than that in the OVX-Form subgroup (Figure 2), 
and such behavior was not detected at all in the OVX-Phys 
and OVX+E
2
-Phys subgroups, where the animals displayed 
very little rubbing activity (Figure 2).
As a result of the statistical analysis of the two phases, 
we found that the face rubbing activity in the OVX-Form and 
OVX+E
2
-Form subgroups was significantly higher during 
both the first (*P<0.01; ***P<0.001) and the second phase 
(***P<0.001) than in the OVX-Phys and OVX+E
2
-Phys 
subgroups (Figure 2).
Figure 2 Diagrams show the time spent with pain-related behavior in OVX-Phys, OVX+e2-Phys, OVX-Form and OVX+e2-Form subgroups.
Notes: (A) Diagram shows the time spent rubbing the injected area during 45 minutes of recording period in 3 minutes intervals (blocks 1–15) in all four subgroups. in the 
OVX-Form and OVX+e2-Form subgroups, the two phases of formalin action are clearly distinguishable: the first phase (block 1, first grayed out area) lasted ~3–4 minutes 
and was followed by a quiescent period of 9–10 minutes (block 2–4); the second phase lasted ~30–33 minutes (block 5–15, second grayed out area). The rubbing activity 
in OVX+e2-Form subgroup was more pronounced than that in the OVX-Form subgroup. The biphasic pain-related behavioral pattern does not appear in the OVX-Phys 
and OVX+e2-Phys subgroups. (B, C) Diagrams show the rubbing activity in the two phases in all four subgroups. The subcutaneous formalin injection (OVX-Form and 
OVX+e2-Form) induced a significant increase in rubbing activity in both the first and the second phase when compared with that in the saline-treated animals (OVX-Phys 
and OVX+e2-Phys) (*P<0.01; ***P<0.001). In both phases, pretreatment with estradiol had a significant enhancing effect on the formalin-induced nociceptive behavior when 
compared with the OVX-Form subgroup (#P<0.05; ###P<0.001).
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Data obtained from OVX-Form and OVX+E
2
-Form 
subgroups show that chronic 17β-estradiol pretreatment sig-
nificantly increased the nociceptive behavior in both phases 
(#P<0.05; ###P<0.001; Figure 2).
c-Fos in the Tnc
Microscopic examination of the immunostained transverse 
sections of medulla containing the TNC revealed c-Fos immu-
noreactivity in the nuclei of the neurons. In the OVX-Form 
and OVX+E
2
-Form subgroups, unilateral sc formalin injec-
tion produced an increase in the number of c-Fos-IR neurons 
in the dorsal, superficial area of the ipsilateral TNC when 
compared with the non-treated contralateral side ( Figure 3). 
This increase was significant at all levels along the rostrocau-
dal axis, in accordance with the somatotopic representation 
(*P<0.05; **P<0.01; ***P<0.001;+ P<0.05;++ P<0.01;+++ 
P<0.001; Figure 4).
In the OVX+E
2
-Form subgroup, the effect of formalin 
on the number of c-Fos-IR neurons seems to be similar, 
but more pronounced than that in the OVX-Form subgroup 
(Figure 3). The results of statistical analysis show that this 
chronic 17β-estradiol-induced increase in the formalin-
related activation of the second-order trigeminal neurons is 
significant at several levels of the TNC along the rostrocaudal 
axis (#P<0.05; ##P<0.01; ###P<0.001; Figure 4). On the 
contralateral sides of the TNCs, there were no significant 
differences either between the subgroups or between the 
different levels along the rostrocaudal axis (Figure 4).
Discussion
Although, there is a clear female predominance in cranio-
facial pain disorders suggesting the modulatory role of sex 
hormones, there are only relatively few and conflicting 
studies, which investigated their influence on the trigeminal 
nociception. In the present experiments, we examined the 
effect of chronic, stable high 17β-estradiol level in serum 
on trigeminal pain and trigeminal activation in orofacial 
formalin test of rat.
The source of estradiol found in OVX rats is probably 
extragonadal.27 On the other hand, the used chronic estradiol 
Figure 3 Photos of the c-Fos immunostained transverse sections of dorsolateral medulla containing the spinal Tnc from the OVX-Form and OVX+e2-Form subgroups. 
Inserts show the framed regions in greater magnification.
Notes: On the ipsilateral side (B, D), more c-Fos-immunoreactive neurons can be observed than on the contralateral side (A, C) in both subgroups. after formalin injection, 
there is an increased number of c-Fos-immunoreactive neurons on the ipsilateral side in the OVX+e2-Form subgroup (D) compared to the OVX-Form subgroup (B). in these 
two subgroups, difference between the contralateral sides (A, C) cannot be observed. scale bar: 500 and 50 µm.
Abbreviation: Tnc, trigeminal nucleus pars caudalis.
OVX-Form
contralateral
OVX+E2-Form
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pretreatment resulted in an average serum 17β-estradiol level 
of 61.29 pg/mL in OVX+E
2
 group of rats, which is compa-
rable with the value of serum concentration of estradiol in 
cycling rats during the proestrus phase, when the estrogen 
concentration is at its peak level.28–31
Our data show that the chronic 17β-estradiol treatment 
was pronociceptive in orofacial formalin test compared 
with the control, ovariectomized, female rats. The effect of 
estradiol was shown in both the first and the second phase of 
orofacial formalin test, where the first phase is caused by the 
direct chemical stimulation of the nociceptors by the formalin 
solution, while the second phase is the result of peripheral 
inflammation.32 Furthermore, this chronic estradiol treat-
ment enhanced the formalin-induced trigeminal activation at 
the level of second-order trigeminal neurons located in the 
TNC, as reflected by the increased c-Fos immunoreactivity, 
which is one of the anatomical markers of the pain-induced 
neuronal activity.33
The molecular basis for estrogen to directly regulate the 
pain transmission at the level of trigeminal system is mediated 
by estrogen receptors, which has three known types: estrogen 
receptor alpha (ERα), ERβ and G-protein-coupled estrogen 
receptor (or G-protein-coupled receptor-30 [GPR30]). These 
receptors are present in the trigeminal system. ERα can be 
observed in 22% of primary trigeminal neurons of rat, where 
it is found mainly in nuclei of cells with larger diameter and in 
cytoplasm of smaller neurons.34 Satellite glia in the trigeminal 
ganglion of rat also express ERα.35 ERβ is also present in 
both small to large neurons in the Gasserian ganglion of rat, 
but not in the satellite glia.35 GPR30 receptor can be observed 
in 35% of neurons in trigeminal ganglion of rat and shows 
cytoplasmatic localization mainly in small diameter neurons 
with unmyelinated axons, but it is present in neurons with 
myelinated axons with a broad range of cell sizes, too.34 ERα 
and GPR30 are colocalized in 10% of primary trigeminal 
neurons of rat.34 In superficial laminae of rat TNC, ERα 
and ERβ proteins are co-expressed by neurons,18 and in this 
area, ERα was shown to be present in nociceptive-responsive 
neurons.36 GPR30 IR cells were also localized in the mouse 
TNC.37 In human TNC, ERα immunostaining was found in 
the nucleus and cytoplasm of neurons and glial cells and in 
the nerve fibers; ERβ was detected in the cytoplasm of neu-
ronal cells.38 Experimental data show that the modulation of 
these receptors results in well-defined changes of trigeminal 
pain processing. In temporomandibular joint inflammation 
induced by Complete Freund’s Adjuvant (CFA), estradiol 
potentiated the effect in dose-dependent manner and the 
blocking of estrogen receptors by an antagonist was able to 
Figure 4 Diagram shows the mean number of c-Fos-immunoreactive cells in the superficial area of the spinal trigeminal nucleus pars caudalis (TNC) at different levels along 
the rostrocaudal axis. 
Notes: Formalin produced a significant increase in number of c-Fos-immunoreactive neurons on the ipsilateral side of the TNC in the OVX-Form (*P<0.05; **P<0.01; 
***P<0.001) and OVX+e2-Form (
+P<0.05; ++P<0.01; +++P<0.001) subgroups when compared with the contralateral side at different levels along the rostrocaudal axis. The effect 
of formalin was significantly increased by pretreatment with estradiol (#P<0.05; ##P<0.01; ###P<0.001). There was no significant difference between the contralateral sides.
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evolve anti-inflammatory action.39 It was also shown that 
estrogen receptors located in different parts of the trigeminal 
system might mediate pronociceptive responses to estrogen. 
In the same animal model, estrogen receptor stimulation 
by specific agonists enhanced the secondary mechanical 
allodynia and the authors found in the trigeminal ganglion 
an increased immunoreactivity of the activated extracel-
lular signal-regulated kinase, which is a specific marker of 
pain-induced activation of nociceptor.34 The involvement of 
trigeminal ganglion in this process was shown in primary 
trigeminal cultures: microarray and protein activity assays 
also demonstrated the estrogen-induced activation of ERK.40
Effects of estrogen may manifest through two differ-
ent pathways: a slow genomic and a rapid non-genomic 
 mechanism41,42 and both pathways play important role in 
regulation of trigeminal pain processing. By influencing the 
transcription of certain genes (mitogen-activated protein 
kinase-1, interleukin-1 receptor type I, bradykinin B2 recep-
tor, GABA transporter protein, GABA A receptor subunit 
a6, opioid receptor-like 1 receptor, purinoreceptor P2X3, 
transient receptor potential vanilloid 1 and neuropeptide Y) 
with potential relevance to craniofacial pain, long-lasting 
changes were reported in different cells.35,40,43–46 Estrogen can 
activate intracellular signaling pathways via non-genomic, 
membrane-mediated mechanisms also, which may occur 
within seconds or minutes.40,47–50 These cellular mechanisms 
affect numerous processes, which are essential in trigeminal 
pain perception including the function of endogenous anti-
nociceptive system,51,52 the modulation of the excitability of 
TNC neurons.53 In other studies, alteration in the activation 
mechanisms,54 in the neuronal firing activity48 and in the 
glutamatergic neurotransmission55,56 was demonstrated. On 
the other hand, estrogen-dependent changes were reported in 
the expression of several factors such as calcium/calmodulin-
dependent protein kinase II α, calcitonin gene-related peptide 
or serotonin, as well. These molecules are playing important 
role during pain processing.57–59
Our present data on the pronociceptive effect of estradiol 
are supported by earlier studies. In ovariectomized rats, 
estradiol valerate replacement, administered as a single, 
sc injection, increased primary (in masseter muscle) and 
secondary (in whisker pad) facial allodynia after CFA-
induced inflammation of masseter muscle mediated by ERK 
activation in the trigeminal ganglion.49 Kou et al39 reported 
that in ovariectomized rats 17β-estradiol, subcutaneously 
administered for 10 days, potentiated the inflammation and 
exacerbated the pain-induced decrease in the food intake 
in temporomandibular joint inflammation model. The 
 inflammation was induced by intraarticular injection of CFA 
and the effect was dose-dependent. The authors discuss the 
possibility of estrogen effect through the nuclear factor-κB 
(NF-κB) pathway inducing the enhancement of the DNA-
binding activity of NF-κB and the increased transcription of 
its target genes in the synovial membrane. In another experi-
ment, a single sc injection of 17β-estradiol, administered 48 
hours before the testing, worsened the thermal hyperalgesia 
in orofacial inflammation caused by sc injected carrageenan 
in ovariectomized rats, which may be caused by the decreased 
α
2
-adrenoceptor-mediated inhibition of nociception and 
hyperalgesia.60 High 17β-estradiol for 2 days, mimicking the 
plasma levels of estrogen in proestrus, significantly increased 
the duration of pain-related behavior (eye wipe test induced 
by capsaicin) and the activation of trigeminal neurons in TNC 
indicated by c-Fos immunoreactivity. The authors conclude 
that the effect may be in part due to the estrogen-dependent 
increases in mRNA of transient receptor potential vanilloid 
1 and anoctamin 1 in TNC, which have important role in 
trigeminal pain.46
The complexity of the possible mechanisms involved 
may explain the conflicting data on the effect of estrogen on 
trigeminal pain and trigeminal system. Antinociceptive effect 
of single sc estradiol replacement administered 18–24 hours 
prior to the nociceptive testing was shown by Flores et al61 
on facial pain-related behavior induced by intracisternally 
injected N-methyl-d-aspartic acid. In other experiments, pro-
nociceptive effect of low serum level of estrogen was reported 
in rats in the temporomandibular joint inflammation,50,62,63 in 
the orofacial formalin model,17 in the basic facial mechanical 
pain threshold45 or after ligature of the masseter tendon.64 
There are also results, however, which show that serum level 
of estrogen do not have any effect on trigeminal pain for 
example in the eye wipe test after ten-day long pretreatment 
with daily sc 17β-estradiol-3-benzoate54 and in the masseter 
inflammation in normally cycling female and male rats.51 
Similarly, estradiol benzoate, given subcutaneously 48 hours 
prior to the nociceptive testing, had no effect in rats on facial 
pain-related behavior induced by intracisternally injected 
NMDA in males, in ovariectomized females and in normally 
cycling females tested at proestrus or diestrus stages.65
Conclusion
We can conclude that chronic 17β-estradiol pretreatment 
was able to significantly influence both the formalin-induced 
nociceptive behavior and the c-Fos expression at the level 
of trigeminal system suggesting its pronociceptive effect on 
the trigeminal pain and the potentiation of activation of TNC 
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neurons. For the first time, we maintained continuously high 
17β-estradiol serum level for a relatively longer period (21 
days) in ovariectomized female rats, excluding the effect of 
other sexual hormones in the orofacial formalin test. The 
estrogen receptors are present in all key areas of trigeminal 
nociception, including the trigeminal ganglion and the TNC, 
and we hypothesize that the hormone may influence the 
neuronal processes induced by pain through the increase 
of mRNA of transient receptor potential vanilloid 1 and 
anoctamin 1 in TNC, or modulation of the NF-κB pathway 
or activation of ERK in the trigeminal ganglion.
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